These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30696851)

  • 61. Protein-engineered molecules carrying GAD65 epitopes and targeting CD35 selectively down-modulate disease-associated human B lymphocytes.
    Manoylov IK; Boneva GV; Doytchinova IA; Mihaylova NM; Tchorbanov AI
    Clin Exp Immunol; 2019 Sep; 197(3):329-340. PubMed ID: 31009057
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 63. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 64. GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial.
    Krause S; Landherr U; Agardh CD; Hausmann S; Link K; Hansen JM; Lynch KF; Powell M; Furmaniak J; Rees-Smith B; Bonifacio E; Ziegler AG; Lernmark A; Achenbach P
    Diabetes Care; 2014 Jun; 37(6):1675-80. PubMed ID: 24598244
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
    Borg H; Fernlund P; Sundkvist G
    Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.
    Wyatt RC; Brigatti C; Liberati D; Grace SL; Gillard BT; Long AE; Marzinotto I; Shoemark DK; Chandler KA; Achenbach P; Gillespie KM; Piemonti L; Lampasona V; Williams AJK
    Diabet Med; 2018 Jul; 35(7):954-963. PubMed ID: 29577424
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
    Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
    Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
    Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
    J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunomodulation with human recombinant autoantigens.
    Lernmark A; Agardh CD
    Trends Immunol; 2005 Nov; 26(11):608-12. PubMed ID: 16153889
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suppression of Disease-Associated B Lymphocytes by GAD65 Epitope-Carrying Protein-Engineered Molecules in a Streptozotocin-Induced Mouse Model of Diabetes.
    Manoylov IK; Boneva GV; Doytchinova IA; Mihaylova NM; Tchorbanov AI
    Monoclon Antib Immunodiagn Immunother; 2019 Oct; 38(5):201-208. PubMed ID: 31603741
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome.
    Gu Urban GJ; Friedman M; Ren P; Törn C; Fex M; Hampe CS; Lernmark Å; Landegren U; Kamali-Moghaddam M
    Sci Rep; 2015 Jun; 5():11196. PubMed ID: 26080009
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
    Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
    Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.
    Hagopian WA; Karlsen AE; Gottsäter A; Landin-Olsson M; Grubin CE; Sundkvist G; Petersen JS; Boel E; Dyrberg T; Lernmark A
    J Clin Invest; 1993 Jan; 91(1):368-74. PubMed ID: 8423232
    [TBL] [Abstract][Full Text] [Related]  

  • 77. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [TBL] [Abstract][Full Text] [Related]  

  • 78. GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes.
    Miao D; Guyer KM; Dong F; Jiang L; Steck AK; Rewers M; Eisenbarth GS; Yu L
    Diabetes; 2013 Dec; 62(12):4174-8. PubMed ID: 23974918
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
    Park Y; Lee H; Takino H; Abiru N; Kawasaki E; Eisenbarth GS
    Acta Diabetol; 2001; 38(1):51-6. PubMed ID: 11487177
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
    Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
    Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.